The Power of Collaboration is a joint project between ISSUP and the GWN. This initiative delves into three critical areas in substance use disorder (SUD) treatment for women:
MIND THE GAP: GLOBAL SURVEY EXAMINING ACCESS FOR SUBSTANCE...
The International Nurses Society on Addictions (IntNSA) invites you to submit an abstract for oral and/or poster session at the Annual Educational Conference!
T...
The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of...
In Spain, the offer of prevention programmes is very varied and structured, but today the challenge remains how to put evidence into practice. European Commission define a best practice as “a relevant policy or intervention...
BACKGROUND: Drug dependence is a public health problem that requires trained professionals to effectively address this issue. The aim of this study was to analyse postgraduate university training programs specialising in addictions in Spain...
Background: Over the past decade, drug-related overdoses have seen a significant rise both in North America and globally. The COVID-19 pandemic has further emphasised the urgent need for safer supply programs to replace unregulated...
BACKGROUND:
Substance use increases the risk of damage to executive and cognitive functions. Manifested by a range of clinical symptoms, such impairments may affect people’s coping with everyday activities and their abilities to...
The DIMS annual report 2022 covers the concentrations, adulterations, and other relevant information produced by DIMS in the past year, and in doing so forms a topical image of the Dutch drug market. Spread out over all Dutch provinces, the...
The consultation on the UK clinical guidelines for alcohol treatment is now open.
This consultation asks you to review individual chapters from the draft UK clinical guidelines for alcohol treatment.
Each...
Background: Physical health problems are common in people receiving opioid agonist treatment (OAT). A study was conducted on these health issues in OAT patients in the Czech Republic and Norway from 2010 to 2019, with a focus on gender...
Xylazine is an α2-agonist increasingly prevalent in the illicit drug supply. Our objectives were to curate information about xylazine through social media from people who use drugs (PWUDs). Specifically, we sought...
The fourth European Conference on Addictive Behaviours and Dependencies took place in Lisbon from 23–25 November 2022.
Under the overarching theme of Global Addictions, LxAddictions22 showcased cutting-edge research to help characterise...
INTRODUCTION: In Spain, the offer of prevention programmes is very varied and structured, but today the challenge remains how to put evidence into practice. European Commission define a best practice as “a relevant policy or intervention...
INTRODUCTION: Prevention science and quality standards of drug prevention in the EU and in the world have developed in recent decades. Progress has been made in quality development in Croatia, but the experience of the process of improving...